Skip to main content
Premium Trial:

Request an Annual Quote

Lentigen Extends Army Program for Lentiviral Biodefense

NEW YORK (GenomeWeb News) – Lentigen has signed a contract with the US Army that extends a 2006 agreement that uses the company’s lentiviral vector technology for biodefense, the company said today.
The Army will use the lentiviral technology, which is used to deliver genes or gene silencing sequences into cells, at its Edgewood Chemical Biological Center.
Lentigen CSO Boro Dropulic said the technology has been successful in helping to produce an antibody targeted to anthrax. The lentiviral technology also has been used to produce “difficult-to-express proteins at levels suitable for further development and potential commercialization,” Dropulic added.
“The unique capabilities of these extraordinary vectors could enhance the production of cellular products used in so many aspects of our development programs,” Army Scientific Advisor for Biotechnology James Valdes said in a statement.
Financial terms of the agreement were not released.

The Scan

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.

Algorithm Teases Out Genetic Ancestry in Individuals at Biobank Scale

Researchers develop an algorithm known as Rye to tease apart ancestry fractions in admixed individuals at a biobank-scale, applying it to 488,221 UK Biobank participants in Nucleic Acids Research.

Multi-Ancestry Analysis Highlights Comparable Common Variants at Complex Trait-Linked Loci

Researchers in Nature Genetics examine common variants implicated in more than three dozen conditions, estimating genetic effect similarities across ancestry tracts in admixed individuals.

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.